Molecular targets in spinal cord injury

Stefan Klussmann1, Ana Martin-Villalba

  • 1Tumorimmunology Program, Division of Immunogenetics, German Cancer Research Center, Heidelberg, Germany.

Journal of Molecular Medicine (Berlin, Germany)
|August 3, 2005
PubMed
Summary

Spinal cord injury (SCI) hinders axon regeneration due to inhibitory signals and damage. Current treatments focus on creating a permissive environment and boosting intrinsic axon growth potential to restore function.